Ralph T. Salvagno, CEO at PetLife Pharmaceuticals, Inc. (PTLF), bought 12,050,000 shares at $0.64 ($6.0M) on 2016-02-12, disclosed to the SEC on 2017-03-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.25 | 100,000 | $25K | 0.4% |
| 2 | $0.46 | 540,000 | $248K | 4.1% |
| 3 | $0.64 | 250,000 | $160K | 2.7% |
| 4 | $0.50 | 11,160,000 | $5.6M | 92.8% |
| Total | $0.50 avg | 12,050,000 | $6.0M | 100% |